Jove
Visualize
Contact Us

Related Concept Videos

Bacterial Phylum Spirochaetes01:30

Bacterial Phylum Spirochaetes

Spirochetes, unique bacteria in the phylum Spirochaetes, are gram-negative, motile, tightly coiled, slender, and flexible. They inhabit aquatic sediments and animals, with some causing diseases like syphilis. Spirochetes are classified into eight genera based on habitat, pathogenicity, phylogeny, and characteristics.Their distinctive motility arises from endoflagella, located within the cell’s periplasm. These endoflagella anchor at the cell poles and extend along the cell length, encased by a...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors affecting detection and quantification of Schistosoma haematobium eggs in pooled urine samples.

PLoS neglected tropical diseases·2026
Same author

Retrospective analysis of emerging health threats by shoreland Travax®, 2019-2024.

Journal of travel medicine·2026
Same author

Quantifying the Public Health Impact of Lyme Disease in Minnesota: A Simulation Analysis of Reported and Unreported Cases.

Journal of health economics and outcomes research·2025
Same author

Sensitivity analysis of limit of detection estimation using probit regression.

American journal of clinical pathology·2025
Same author

Integrating Human and Animal Health in the STOP Spillover Outbreak Scenarios.

Disaster medicine and public health preparedness·2025
Same author

SARS-CoV-2 genomic surveillance using self-collected saliva specimens during occupational testing programs.

Frontiers in public health·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples
06:05

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples

Published on: June 14, 2024

Antibiotics for leptospirosis.

David M Brett-Major1, Rodney Coldren

  • 1U.S. Military Tropical Medicine, Navy Medicine Manpower, Personnel, Training and Education Command (NAVMED MPT&E),Bethesda, MD, USA. dmbrettmajor@gmail.com

The Cochrane Database of Systematic Reviews
|February 17, 2012
PubMed
Summary

The benefit of antibiotic therapy for leptospirosis remains unclear, with limited evidence from randomized trials. While antibiotics may reduce illness duration, further research is needed to establish their efficacy, especially in severe cases.

More Related Videos

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

Application of CRISPR Interference (CRISPRi) for Gene Silencing in Pathogenic Species of Leptospira
14:49

Application of CRISPR Interference (CRISPRi) for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

Related Experiment Videos

Last Updated: May 24, 2026

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples
06:05

Polymerase Chain Reaction and Dot-Blot Hybridization for Leptospira Detection in Water Samples

Published on: June 14, 2024

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms
08:51

A Modular Workflow for Quantitative, Structural and Functional Analysis of Leptospira Biofilms

Published on: December 19, 2025

Application of CRISPR Interference (CRISPRi) for Gene Silencing in Pathogenic Species of Leptospira
14:49

Application of CRISPR Interference (CRISPRi) for Gene Silencing in Pathogenic Species of Leptospira

Published on: August 14, 2021

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Pharmacology

Background:

  • Leptospirosis is a globally distributed bacterial infection with significant public health impact and variable mortality rates.
  • The efficacy of antibiotic treatment for leptospirosis has not been clearly established, necessitating further investigation.

Purpose of the Study:

  • To systematically evaluate the risks and benefits of antibiotic therapy in the management of leptospirosis.
  • To synthesize evidence from randomized clinical trials to inform treatment guidelines.

Main Methods:

  • A comprehensive search of multiple electronic databases (Cochrane Hepato-Biliary Group Register, CENTRAL, MEDLINE, EMBASE, Science Citation Index Expanded) was conducted up to November 2011.
  • Included studies were randomized clinical trials assessing antibiotic use for leptospirosis, with a broad range of study types incorporated to identify potential harms.
  • Systematic abstraction of included trials and excluded studies was performed, with analyses conducted following Cochrane Handbook guidelines.

Main Results:

  • Seven randomized trials (403 patients) were included; four compared antibiotics with placebo, and three compared different antibiotic regimens.
  • Trials exhibited a high risk of bias, and meta-analysis was limited. No significant differences in mortality were found between antibiotic and placebo groups (OR 1.16, 95% CI 0.23 to 5.95).
  • Antibiotic therapy showed a trend towards reducing clinical illness duration (MD -4.04, 95% CI -8.66 to 0.58) but not duration of fever or hospitalization. No significant differences were observed when comparing different antibiotics.

Conclusions:

  • There is insufficient evidence to recommend or refute the use of antibiotics for leptospirosis treatment.
  • While antibiotics might shorten illness duration in survivors, this finding was not statistically significant.
  • Further high-quality clinical research is required to clarify the role of antibiotics, particularly in severe leptospirosis, and to compare various therapeutic options against placebo.